Future Surgical Gel

About Cresilon

Cresilon is a commercial-stage medical device company addressing the critical global challenge of uncontrolled bleeding through its innovative, plant-based hydrogel technology. Its flagship products, TRAUMAGEL (FDA-cleared for human trauma) and VETIGEL (for veterinary use), are designed to achieve rapid hemostasis across diverse wound geometries. The company has gained significant recognition, including being named the #1 most innovative company in medical devices by Fast Company in 2026, and is focused on expanding the adoption of its life-saving technology across pre-hospital, hospital, and veterinary care settings.

Therapeutic Areas